These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24613004)

  • 21. Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro).
    Chamberlin JR; Lardi AB; McKeever LS; Wang MH; Ramadurai G; Grunenwald P; Towne WP; Grassman ED; Leya FS; Lewis BE; Stein LH
    Catheter Cardiovasc Interv; 1999 Jun; 47(2):143-7; discussion 148. PubMed ID: 10376492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-Center Experience Comparing the Application of Small-Caliber versus Large-Caliber Arterial Access Closure in a Consecutive Series of Patients.
    Baumann F; Yates T; Gandhi R; Benenati J; Pena C; Katzen BT
    J Vasc Interv Radiol; 2015 Sep; 26(9):1285-9. PubMed ID: 26070428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized trial comparing compression, Perclose Proglide and Angio-Seal VIP for arterial closure following percutaneous coronary intervention: the CAP trial.
    Martin JL; Pratsos A; Magargee E; Mayhew K; Pensyl C; Nunn M; Day F; Shapiro T
    Catheter Cardiovasc Interv; 2008 Jan; 71(1):1-5. PubMed ID: 18098171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective evaluation of safety and effectiveness of the EXOSEAL vascular closure device for single vascular closure and closure after repeat puncture in diagnostic and interventional radiology: single-center experience.
    Boschewitz JM; Andersson M; Naehle CP; Schild HH; Wilhelm K; Meyer C
    J Vasc Interv Radiol; 2013 May; 24(5):698-702. PubMed ID: 23622041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long term clinical outcomes after deployment of femoral vascular closure devices in coronary angiography and percutaneous coronary intervention.
    Lee SW; Ho HH; Kong SL; Lam YM; Siu CW; Miu KM; Lam L; Chan HW
    Catheter Cardiovasc Interv; 2010 Feb; 75(3):345-8. PubMed ID: 19937775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of arterial closure devices in antegrade and retrograde punctures.
    Chiu AH; Vander Wal R; Tee K; Knight R; Coles SR; Nadkarni S
    J Endovasc Ther; 2008 Jun; 15(3):315-21. PubMed ID: 18540693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and rationale of the AngioSeal versus the Radial approach In acute coronary SyndromE (ARISE) trial: a randomized comparison of a vascular closure device versus the radial approach to prevent vascular access site complications in non-ST-segment elevation acute coronary syndrome patients.
    de Andrade PB; E Mattos LA; Tebet MA; Rinaldi FS; Esteves VC; Nogueira EF; França JÍ; de Andrade MV; Barbosa RA; Labrunie A; Abizaid AA; Sousa AG
    Trials; 2013 Dec; 14():435. PubMed ID: 24345099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and time-to-hemostasis of antegrade femoral access closure using the ExoSeal vascular closure device: a retrospective single-center study.
    Boschewitz JM; Pieper CC; Andersson M; Nadal J; Schild HH; Meyer C
    Eur J Vasc Endovasc Surg; 2014 Nov; 48(5):585-91. PubMed ID: 25201516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Large calibre arterial access device closure for percutaneous aortic valve interventions: use of the Prostar system in 118 cases.
    Cockburn J; de Belder A; Brooks M; Hutchinson N; Hill A; Trivedi U; Hildick-Smith D
    Catheter Cardiovasc Interv; 2012 Jan; 79(1):143-9. PubMed ID: 21538787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arterial access-site complications after use of a vascular closure device related to puncture height.
    Sartorius B; Behnes M; Ünsal M; Hoffmann U; Lang S; Mashayekhi K; Borggrefe M; Akin I
    BMC Cardiovasc Disord; 2017 Feb; 17(1):64. PubMed ID: 28209184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous removal using Perclose ProGlide closure devices versus surgical removal for weaning after percutaneous cannulation for venoarterial extracorporeal membrane oxygenation.
    Hwang JW; Yang JH; Sung K; Song YB; Hahn JY; Choi JH; Gwon HC; Choi SH
    J Vasc Surg; 2016 Apr; 63(4):998-1003.e1. PubMed ID: 26826058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of collagen-based vascular closure devices in patients with vs. without severe peripheral artery disease.
    Kara K; Kahlert P; Mahabadi AA; Plicht B; Lind AY; Longwitz D; Bollow M; Erbel R
    J Endovasc Ther; 2014 Feb; 21(1):79-84. PubMed ID: 24502487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Practices and complications of vascular closure devices and manual compression in patients undergoing elective transfemoral coronary procedures.
    Smilowitz NR; Kirtane AJ; Guiry M; Gray WA; Dolcimascolo P; Querijero M; Echeverry C; Kalcheva N; Flores B; Singh VP; Rabbani L; Kodali S; Collins MB; Leon MB; Moses JW; Weisz G
    Am J Cardiol; 2012 Jul; 110(2):177-82. PubMed ID: 22482861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and utility of total percutaneous endovascular aortic repair with a single Perclose ProGlide closure device.
    Ichihashi T; Ito T; Kinoshita Y; Suzuki T; Ohte N
    J Vasc Surg; 2016 Mar; 63(3):585-8. PubMed ID: 26506938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of gender on femoral access complications secondary to application of a collagen-based vascular closure device.
    Eggebrecht H; von Birgelen C; Naber C; Kröger K; Schmermund A; Wieneke H; Bartel T; Wörtgen U; Baumgart D; Haude M; Erbel R
    J Invasive Cardiol; 2004 May; 16(5):247-50. PubMed ID: 15152129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two-Device Closure Method for Large Diameter Arteriotomies in Percutaneous Endovascular Aortic Repair.
    McCarthy CK; Maqbool F; Gierman JL
    Ann Vasc Surg; 2020 Jan; 62():191-194. PubMed ID: 31449950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bleeding and vascular complications at the femoral access site following percutaneous coronary intervention (PCI): an evaluation of hemostasis strategies.
    Tavris DR; Wang Y; Jacobs S; Gallauresi B; Curtis J; Messenger J; Resnic FS; Fitzgerald S
    J Invasive Cardiol; 2012 Jul; 24(7):328-34. PubMed ID: 22781471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suitability of Exoseal vascular closure device for antegrade femoral artery puncture site closure.
    Schmelter C; Liebl A; Poullos N; Ruppert V; Vorwerk D
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):659-68. PubMed ID: 23070109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness and complications of vascular access closure devices after interventional procedures.
    Sesana M; Vaghetti M; Albiero R; Corvaja N; Martini G; Sivieri G; Colombo A
    J Invasive Cardiol; 2000 Aug; 12(8):395-9. PubMed ID: 10953101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 24h and 30 day outcome of Perclose Proglide suture mediated vascular closure device: An Indian experience.
    Vinayakumar D; Kayakkal S; Rajasekharan S; Thottian JJ; Sankaran P; Bastian C
    Indian Heart J; 2017; 69(1):37-42. PubMed ID: 28228304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.